241-250 of 393 results
Allens acts for Healthscope on Asian pathology sale
Allens has advised Healthscope Limited, one of Australia's leading private healthcare operators, on the sale of its Asian pathology operations in Singapore, Malaysia and Vietnam to funds managed by ...
Recent developments in non-executive director remuneration
Encouraging share ownership by non-executive directors through non-executive director share rights plans is set to increase following a recent ATO class ruling. ...
Report: An update on our predictions for the year ahead across the private equity market
The first half of 2018 has seen a flurry of public-to-private activity that should continue to keep dealmakers busy for the remainder of the calendar year However the mountain of dry powder competing for limited quality investment opportunities remains an issue that has prompted a diversification in ...
Allens acts for Charter Hall on Folkestone acquisition
Allens has advised Charter Hall Group (Charter Hall) on its proposed acquisition of Folkestone Limited (Folkestone). The acquisition, structured as a scheme of arrangement, is valued at $205 ...
Allens acts for CKI on APA takeover
Allens has advised a consortium led by CK Infrastructure (CKI) on a proposed A$13 billion acquisition of listed Australian energy infrastructure business, APA. The deal has been structured by way o ...
Corporate law developments
Welcome to our monthly snapshot of regulatory updates and other developments in corporate law We know you are busy so our focus is on capturing key issues ...
Linklaters Insights: A Cross-Border Guide to Joint Ventures
This Cross-Border Guide considers questions that commonly arise on joint venture deals and how they can be resolved in 26 jurisdictions While no two joint venture deals are the same we hope this is a useful guide to some of the main features of doing cross-border deals ...
Allens advises Clearskincare on $127.4m acquisition
Allens has advised the founders of Clearskincare on the sale of the brand's clinic and products businesses to Australian Pharmaceutical Industries (API) for $127.4 million. Under the deal, API will ...
Allens advises PEP on acquisition of LifeHealthcare
Allens has advised private equity fund manager Pacific Equity Partners (PEP) in relation to the acquisition of ASX-listed LifeHealthcare Group Limited (LifeHealthcare) by Pacific Health Supplies ...
Defamation law developments in the digital context
The NSW Attorney-General has released the long-awaited statutory review of the Defamation Act 2005 (NSW), recommending that consideration be given to certain changes to the Model Defamation Provisions that form the basis for the National Uniform Defamation Law. The High Court's decision in Trkulja v ...